Indivior PLC
General ticker "INDV" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.0B (TTM average)
Indivior PLC follows the US Stock Market performance with the rate: 53.1%.
Estimated limits based on current volatility of 3.6%: low 30.53$, high 32.80$
Factors to consider:
- Total employees count: 1164 as of 2023
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [20.98$, 42.24$]
- 2026-12-31 to 2027-12-31 estimated range: [16.51$, 34.28$]
Financial Metrics affecting the INDV estimates:
- Positive: with PPE of 14.6 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of -0.60 <= 0.01
- Positive: Operating profit margin, % of 21.15 > 18.38
- Negative: Shareholder equity ratio, % of -8.24 <= 19.40
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of -1.47 <= -0.63
- Positive: Return on assets ratio (scaled to [-100,100]) of 14.88 > 6.11
- Negative: 0.73 < Interest expense per share per price, % of 1.00
- Positive: Inventory ratio change, % of -2.04 <= -0.75
Short-term INDV quotes
Long-term INDV plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $1,188.00MM | $1,239.00MM |
| Operating Expenses | $1,156.00MM | $977.00MM |
| Operating Income | $32.00MM | $262.00MM |
| Non-Operating Income | $-18.00MM | $-23.00MM |
| Interest Expense | $41.00MM | $45.00MM |
| R&D Expense | $107.00MM | $97.00MM |
| Income(Loss) | $14.00MM | $239.00MM |
| Taxes | $11.00MM | $29.00MM |
| Profit(Loss)* | $2.00MM | $210.00MM |
| Stockholders Equity | $-348.00MM | $-98.00MM |
| Inventory | $178.00MM | $153.00MM |
| Assets | $1,319.00MM | $1,204.00MM |
| Operating Cash Flow | $36.00MM | $-27.00MM |
| Capital expenditure | $29.00MM | $66.00MM |
| Investing Cash Flow | $69.00MM | $-66.00MM |
| Financing Cash Flow | $-102.00MM | $-30.00MM |
| Earnings Per Share** | $0.02 | $1.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.